Lipinski’s Rule of 5 in Modern Drug Discovery: Navigating Oral Bioavailability and Beyond
In the fast-evolving landscape of pharmaceutical research, few concepts remain as foundational yet constantly re-evaluated as Lipinski’s Rule of 5 (Ro5). Introduced by Christopher Lipinski in 1997, this rule revolutionized how medicinal chemists screen chemical libraries, providing a rapid heuristic to evaluate whether a chemical compound possesses the physicochemical properties required...
0 Commenti 0 condivisioni 2 Views
Bout-ye https://bout-ye.com